Overview of Atea Pharmaceuticals: antiviral biotech
Atea PharmaceuticalsAVIR7.38 $BuyService in partnership with Tinkoff Investments. Quotes are updated every 15 minutes Atea Pharmaceuticals (Nasdaq: AVIR) — American pharmaceutical company, which appeared in 2012 in Boston, Massachusetts, and develops antiviral agents in the clinical stages.